We are live on ! Find out more
IH

iHuman
IH

7 hedge funds and large institutions have $7.8M invested in iHuman in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

40% more funds holding

Funds holding: 5 → 7 (+2)

0.05% more ownership

Funds ownership: 2.14% → 2.19% (+0.05%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less capital invested

Capital invested by funds: $8.47M → $7.8M (-$670K)

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$32.1K
2
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$21.3K
3
Renaissance Technologies
Renaissance Technologies
New York
+$6.69K
4
State Street
State Street
Massachusetts
+$2.76K
5
Morgan Stanley
Morgan Stanley
New York
+$1.36K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$172
Name Holding Trade Value Shares
Change 		Change in
Stake
APA
1
Arisaig Partners (Asia)
Singapore
$7.63M – – –
State Street
2
State Street
Massachusetts
$68.1K +$2.76K +891 +4%
Renaissance Technologies
3
Renaissance Technologies
New York
$44K +$6.69K +2,160 +17%
Citadel Advisors
4
Citadel Advisors
Florida
$30.7K +$32.1K +10,364 New
RhumbLine Advisers
5
RhumbLine Advisers
Massachusetts
$20.4K +$21.3K +6,875 New
Morgan Stanley
6
Morgan Stanley
New York
$3.07K +$1.36K +438 +73%
NA
7
NewEdge Advisors
Louisiana
$624 +$654 +211 New
UBS Group
8
UBS Group
Switzerland
– -$172 -53 Closed

IH Hedge Fund Activity: Q2 2023 in Review

7 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q2 2023, worth a combined $7.8M — down 7.9% from $8.47M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IH positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $32.1K. The largest seller was UBS Group, exiting entirely with an estimated $172 sold.

  • 7 institutional investors held iHuman (IH) as of Q2 2023, up from 5 in Q1 2023.
  • Funds reported $7.8M of iHuman stock for Q2 2023, down 7.9% quarter-over-quarter.
  • 3 funds opened new iHuman positions in Q2 2023 and 1 closed out, a net change of +2 holders.
  • The largest iHuman buyer in Q2 2023 was Citadel Advisors, an estimated $32.1K added.
  • The largest iHuman seller in Q2 2023 was UBS Group, an estimated $172 sold.

Based on aggregated 13F filings for Q2 2023.